CrystEngComm · 2011 · 161 citations · 30 references
Natural SciencesChemistryPharmacologyCrystal StructureStructural BiologyStructure-activity RelationshipsAcid-base ChemistryCoordination ChemistryCrystal ChemistryCrystal SystemsLigand BindingChemical Bonding In CrystalsCo-crystal FormationHydrogen Bond GeometryHydrogen BondingMolecular CrystalsProton Transfer MechanismsProton Transfer ReactionsSalt Co-crystals
Two drug-drug co-crystals of the anti-tuberculosis drugs isoniazid (INH), pyrazinamide (PYR) and 4-aminosalicylic acid (PAS) are reported. The first is the 1 : 1 molecular complex of INH and PAS. The second is the monohydrate of the 1 : 1 complex of PYR and PAS. The crystal structures of both co-crystals are characterized by a number of hydrogen bonded synthons. Hydrogen bonding of the COOH⋯Npyridine type is found in both cases. In the INH : PAS co-crystal, there are two symmetry independent COOH⋯Npyridine hydrogen bonds. In one of these, the H-atom is located on the carboxylic group and is indicative of a co-crystal. In the second case, partial proton transfer occurs across the hydrogen bond, and the extent of proton transfer depends on the temperature. This is more indicative of a salt. Drug-drug co-crystals may have some bearing in the treatment of tuberculosis.
30
Pharmaceutical Cocrystals and Their Physicochemical Properties
N. Schultheiss, Ann Newman · Crystal Growth & Design · 2009 · 1.5K citations · Full text